Impact News +++ Kinross Gold cuts output, boosts shareholder payout (Mining.com) +++ KINROSS Aktie -6,34%

GRAIL INC Aktie

>GRAIL INC Aktienkurs

104.55 EUR +9.2% (TradegateBSX)

Ask: 105.4 EUR / 200 Stück

Bid: 103.85 EUR / 200 Stück

Tagesumsatz: 1245 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

GRAIL INC Aktie über LYNX handeln

Intraday

1 Jahr

>GRAIL INC Performance

1 Woche: +47,9%

1 Monat: +45,5%

3 Monate: +75,9%

6 Monate: +127,5%

1 Jahr: +140,6%

laufendes Jahr: +28,3%

>GRAIL INC Aktie

Profil:

GRAIL, Inc. is a commercial-stage healthcare company focused on multi-cancer early detection testing and services. Its core offering is Galleri, a blood-based screening test designed to detect multiple cancer types before symptoms appear, supporting ..
>Volltext..

Insiderhandel:

>GRAIL INC Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>GRAIL INC Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten

>GRAIL INC Chart & Kurs - NASDAQ

>GRAIL INC News

24.09.26 - 15:42	XFRA: NL0: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN GRAIL INC. DL-,01 NL0 US3847471014 AB/FROM ONWARDS 24.09.2026 15:30 CE...

24.09.26 - 13:25	Positives FDA-Votum beflügelt Grail-Aktie: Kurs springt um über 11 % (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.09.26 - 03:18	FDA Panel Recommends Approval Of GRAIL′s Galleri Multi-Cancer Early Detection Test (RTTNews)
	GRAIL Inc.'s (GRAL) Galleri multi-cancer early detection test has received a favorable vote from the FDA panel, making it one step closer to approval. The FDA's final decision on Galleri is expected in the coming months. The U. S. regulator usually follows the recommendations of its panels, although it is not mandatory to do so....

24.09.26 - 00:30	FDA Advisory Committee Votes In Favor of Approval of GRAIL′s Galleri® Multi-Cancer Early Detection Test (PR Newswire)
	SUNNYVALE, Calif., Sept. 23, 2026 /PRNewswire/ -- GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, today announced a favorable vote from the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee (the......

24.09.26 - 00:01	Insiderhandel: Chief Financial Officer verkauft Aktien von GRAIL im Wert von 382679 USD (Insiderkauf)
	Freidin, Aaron - Vorstand - Tag der Transaktion: 2026-09-21...

24.09.26 - 00:01	Insiderhandel: Chief Executive Officer verkauft Aktien von GRAIL im Wert von 6006379 USD (Insiderkauf)
	Ofman, Joshua J. - Vorstand - Tag der Transaktion: 2026-09-21...

23.09.26 - 13:12	XFRA: INSTRUMENT_SUSPENSION - US3847471014 (XETRA)
	Instrument ID [20193824] (NL0 - US3847471014) suspended...

23.09.26 - 13:12	XFRA: NL0: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL GRAIL INC. DL-,01 NL0 US3847471014 BAW/UFN...

22.09.26 - 05:00	GRAIL Stock Bounces Back Above $100: Can Galleri Sail Through Its FDA Panel Review? (RTTNews)
	Shares of GRAIL Inc. (GRAL) are back above $100 as the company approaches a watershed moment. When we featured GRAL on our site on September 26, 2025, it was trading around $48. It subsequently surged to a 52-week high of $118.84 on January 22, 2026. On August 12, 2026, when we revisited the stock, it had retraced to $73. Yesterday, GRAL rallied more than 33% to close at $107.97....

21.09.26 - 21:36	Positives FDA Gutachten beflügelt Grail Aktie (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

03.09.26 - 22:06	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
	SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of......

01.09.26 - 06:01	Insiderhandel: Chief Financial Officer verkauft Aktien von GRAIL im Wert von 671579 USD (Insiderkauf)
	Freidin, Aaron - Vorstand - Tag der Transaktion: 2026-08-27...

01.09.26 - 06:01	Insiderhandel: Chief Executive Officer verkauft Aktien von GRAIL im Wert von 425098 USD (Insiderkauf)
	Ofman, Joshua J. - Vorstand - Tag der Transaktion: 2026-08-27...

31.08.26 - 22:03	GRAIL to Present at Morgan Stanley′s 24th Annual Global Healthcare Conference (PR Newswire)
	MENLO PARK, Calif., Aug. 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York......

20.08.26 - 15:06	Girard Sharp LLP and The Hall Firm, Ltd. Announces Notice of Class Action For All Persons or Entities Who Acquired Illumina Common Stock in Exchange for GRAIL Securities in the August 18, 2021 Merger Between Illumina and GRAIL (PR Newswire)
	SAN FRANCISCO, Aug. 20, 2026 /PRNewswire/ -- SUMMARY NOTICE OF CLASS ACTION SUPERIOR COURT OF THE STATE OF CALIFORNIA, COUNTY OF SAN MATEO TO: ALL PERSONS OR ENTITIES WHO ACQUIRED ILLUMINA, INC. ("ILLUMINA") COMMON STOCK IN EXCHANGE FOR GRAIL, INC. ("GRAIL") SECURITIES IN THE AUGUST 18,......

11.08.26 - 17:12	GRAIL: Wachstumsdynamik trifft auf entscheidende regulatorische Prüfung (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.26 - 17:15	GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test (PR Newswire)
	MENLO PARK, Calif., Aug. 7, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the U.S. Food and Drug Administration's (FDA) Molecular and Clinical Genetics Panel of the Medical Devices......

05.08.26 - 23:42	GRAIL übertrifft Umsatzprognose für Q2 2026, Aktie gibt nachbörslich nach (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.26 - 22:09	GRAIL, Inc. GAAP EPS of -$2.56 beats by $0.10, revenue of $44.7M beats by $2.3M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

04.08.26 - 16:13	GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm (PR Newswire)
	NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL). Shareholders who purchased shares of GRAL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Idiot heißt einer, insofern Eigenheit in ihm ist. - Georg Wilhelm Friedrich Hegel

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram